NCT01410513 Study Combining SAR245409 With Rituximab or Bendamustine Plus Rituximab in Patients With Indolent Lymphoma, Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE1
NCT01403636 A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia Status COMPLETED Phase PHASE2
NCT01403376 Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide Status COMPLETED Phase PHASE2
NCT01392924 Safety and Pharmacokinetics of SAR245408 Daily Oral in Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT01391533 Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors Status COMPLETED Phase PHASE1
NCT01390818 Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT01389700 Pharmacokinetics, Pharmacodynamics and Safety Evaluation of SAR279356 in Intensive Care Unit Mechanically Ventilated Patients Status TERMINATED Phase PHASE2
NCT01385657 Safety and Tolerability of Dupilumab in Participants With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE1
NCT01378286 Efficacy and Tolerability of Artesunate Amodiaquine Versus Chloroquine in the Treatment of Uncomplicated Plasmodium Vivax Malaria Status COMPLETED Phase PHASE3
NCT01368848 Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC) Status COMPLETED Phase PHASE2
NCT01367444 Phase I/IIA Study of SAR422459 in Participants With Stargardt's Macular Degeneration Status TERMINATED Phase PHASE1/PHASE2
NCT01357330 Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT01355185 Seed Movement in Prostate Brachytherapy Implants: Clinical Measurement and Dosimetric Consequences Status UNKNOWN Phase N/A
NCT01353469 Assessment of Efficacy and Safety of Insuman Comb 25 Versus Novolin® 30R Twice Daily Over 24 Weeks in Type 2 Diabetes Patients With Insulin Therapy Status COMPLETED Phase PHASE3
NCT01349855 Repeated Dosing Study With a New Insulin Glargine Formulation and Lantus® in Patients With Type 1 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT01340157 Fexinidazole (1200mg) Bioavailability Under Different Food Intake Conditions Status COMPLETED Phase PHASE1
NCT01339832 An Observational Study of Xeloda (Capecitabine) and Oxaliplatin Prior and Concurrent To Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer Status COMPLETED Phase N/A